Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellule Daru Darman Iranian is a leading Iranian biotechnology company dedicated to the development and commercialization of advanced regenerative medicine and cell-based therapies. Founded in 2011 and headquartered in Tehran, the company specializes in autologous cell products, which involve using a patient's own cells to treat various conditions. Their portfolio features several approved products, including Cell-Derm for dermatological applications, Cell-Cart for orthopedic cartilage repair, and Cell-Melan for vitiligo treatment. Cellule Daru Darman operates a state-of-the-art GMP-certified facility and maintains strong ties with the Royan Institute to drive innovation in the Middle Eastern biotech landscape. The company's mission is to provide accessible and effective cellular treatments for chronic and debilitating diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellule Daru Darman Iranian.